Calviri

Let’s End Cancer – First in Dogs, Then People

Min Investment: $499
Location: Phoenix, AZ
Expected Close Date: November 21, 2024
Target Raise: $10.00K-$1.23M
Security Price: $3.22
Website: calviri.com

Number of Employees: 24
Cash: $349,758
Revenue: $21,661
Short Term Debt: $294,581
Cost of Goods: $0
Long Term Debt: $0
Net Income: $-5,540,651

Company Description

Calviri is a pre-revenue, pre-market biotech company that has built a vaccine to PREVENT cancer in dogs – NOT ONLY TREAT IT. Our vaccine prevents cancer from starting in the first place.

Amount Raised : $126,759

Reveal the Score by Voting

＿

Additional ratings from other users are needed to determine a viable CrowdScore for this deal.

The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.

ⓘ

The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.

Business Idea

ⓘ

The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.

Business Traction

ⓘ

The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.

Management Team

ⓘ

The value of the company compared to similar companies raising money from investors.

Valuation

Have you done enough research to provide a rating? This is important for your fellow investors.

We only allow one revision to each rating category. Be sure about any changes.

Research Reports

No reports have been submitted

Become a Reporter

Read Our Research Disclaimer

0 Comments

To claim your deal, you must have access to @calviri.com email

Contact support@crowdlustro.com if you need assistance.

@calviri.com